Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0326113 Treatment of Mild and Moderate Alzheimer's Disease
The present invention relates to methods of treatment using [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)- -propyl]-diethyl amine...
2017/0326112 DENTAL ANESTHETIC COMPRISING TETRACAINE AND A VASOCONSTRICTOR FOR INTRANASAL ADMINISTRATION
The present invention relates to tetracaine based anesthetic formulations and methods of use thereof The invention further relates to topical formulations of...
2017/0326111 Method for anesthetizing a body part, organ, or tissue utilizing an anesthetic comprising tetracaine and a...
The present invention relates to tetracaine based anesthetic formulations and methods of use thereof The invention further relates to topical formulations of...
2017/0326110 SOLID PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE AND LOSARTAN
The present invention provides a pharmaceutical composition for the prevention or treatment of cardiovascular disorders containing losartan or a...
2017/0326109 Fixed Dose Combination for Pain Relief Without Edema
The invention provides compositions and methods for individualized therapy of arthritic pain without causing edema, using a non-steroidal anti-inflammatory...
2017/0326108 COMPOSITIONS AND METHODS FOR REDUCING PRION LEVELS
Compositions and methods for reducing the level of prions in a prion-infected cells or host by exposing prion infected cells, tissues and organs to AR-12 and...
2017/0326107 5-HT6 Receptor Antagonists for Use in the Treatment of Alzheimer's Disease with Apathy as Comorbiity
The present invention relates to 5-HT.sub.6 receptor antagonists for the treatment of Alzheimer's disease with comorbid apathy comprising administering an...
2017/0326106 TREATMENT OF AGE RELATED MACULAR DEGENERATION WITH A SMALL ACTIVE CHOROIDAL NEOVASCULARIZATION LESION
Methods for treatment of wAMD with an active CNV lesion of less than 50% of the total lesion size and pharmaceutical compositions for the use therein are...
2017/0326105 MELATONIN-BASED NASAL COMPOSITIONS AND USES THEREOF
Disclosed is an improved composition characterized in containing a combination of melatonin and 5-HTP in a nasal administration for the rapid treatment of...
2017/0326104 IRE-1ALPHA INHIBITORS
Compounds which directly inhibit IRE-1.alpha. activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are...
2017/0326103 LYMPH DIRECTING PRODRUGS
The present invention relates to compounds and their uses, in particular, compounds in the form of prodrugs that promote transport of a pharmaceutical agent to...
2017/0326102 Pharmaceutical Composition Comprising an Artemisinin Derivative for Nasal or Pulmonary Delivery
The present invention relates to pharmaceutical composition for intranasal or pulmonary delivery, wherein the composition comprises an artemisinin derivative...
2017/0326101 FORMULATION FOR EFFECTIVE TOCOTRIENOL DELIVERY
The present invention disclosed a formulation in the form of self-emulsifying drug delivery formulation for improved delivery of tocotrienols comprising a...
2017/0326100 COMPOSITION FOR ACTIVATING LONGEVITY GENE
Disclosed is a composition for activating one or more genes of an XPD gene, a Klotho gene, a Sirt-1 gene, an ERCC8 gene and a FoxO3 gene, which contains a...
2017/0326099 METHODS OF TREATING LIVER DISEASES
The invention provides tricyclic compounds and their use in treating liver disorders, such as non-alcoholic steatohepatitis and related disorders (e.g.,...
2017/0326098 CIS-GNETIN H AND TRANS-GNETIN H AS THERAPEUTIC AGENTS
The cis-isomer and trans-isomers of the plant-derived compound gnetin H are shown have anticancer properties, anti-inflammatory properties, and low toxicity....
2017/0326097 GREEN SYNTHESIS OF REDUCED GRAPHENE OXIDE SILICA NANOCOMPOSITE USING NIGELLA SATIVA SEEDS EXTRACT
The green synthesis of a reduced graphene oxide (rGO) silica (SiO.sub.2) nanocomposite using Nigella sativa seed extract includes mixing a quantity of carbon...
2017/0326096 Selective Targeting of Procoagulant Platelets
The invention relates to a process for identifying procoagulant platelets both in vitro and in vivo, and the identification of compounds which selectively...
2017/0326095 PARENTERAL ESMOLOL FORMULATION
A parenteral formulation of esmolol hydrochloride for use in the treatment of a patient suffering from tachycardia comprising a lyophilized powder consisting...
2017/0326094 USES OF BIOACTIVE LIPIDS
The present invention provides an oxygenated fatty acyl glycerol for use in treating and/or preventing an inflammatory disease a subject.
2017/0326093 TARGETING K-RAS-MEDIATED SIGNALING PATHWAYS AND MALIGNANCY BY PROSTRATIN
The present invention provides method of treating a K-Ras-expressing cancer in a subject comprising administering to the subject a therapeutic amount of...
2017/0326092 ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
The present invention provides an oral pharmaceutical composition of isotretinoin with a reduced dose. The present invention further relates to a process for...
2017/0326091 LOW DOSE ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
The present invention provides a low dose oral pharmaceutical composition of isotretinoin having reduced food effect, in particular no food effect. The present...
2017/0326090 PRODUCTION OF ULTRAPURE EPA AND POLAR LIPIDS FROM LARGELY HETEROTROPHIC CULTURE
Eicosapentaenoic acid (EPA) compositions and EPA-rich polar lipids for prophylactic or therapeutic applications are described. Production from certain cultured...
2017/0326089 AMINOACID-BASED COMPOSITION FOR FIBROELASTIN RECOVERY IN DERMAL CONNECTIVE TISSUES
The present invention relates to compositions containing, as active ingredient, a mixture of amino acids able to stimulate the biosynthesis of elastin and...
2017/0326088 AMINO ACID COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF DISEASE
The subject invention provides therapeutic compositions, and uses thereof for the treatment or amelioration of symptoms of a disease selected from the group...
2017/0326087 CRYSTALLINE POLYMORPHIC FORMS OF MONOSODIUM N-[-8-(2-HYDROXYBENZOYL)AMINO]CAPRYLATE
The present invention relates to crystalline polymorphic forms of monosodium N-[8-(2-hydroxybenzoyl)amino] caprylate ("SNAC"), including two hydrates, a...
2017/0326086 USE OF HEMOGLOBIN EFFECTORS TO INCREASE THE BIOAVAILABILITY OF THERAPEUTIC GASES
Methods which increase the bioavailability of beneficial gases in the circulatory system are provided. The methods involve administering agents that changes...
2017/0326085 Glycolic acid and/or D-lactic acid for the treatment of neurodegenerative diseases
A method of treatment of a neurodegenerative disease which is associated with a decline in mitochondrial activity, includes administering to a person in need...
2017/0326084 NOVEL IMAGING COMPOSITION AND USES THEREOF
The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal...
2017/0326083 METHOD OF TREATING CARDIOVASCULAR EVENTS USING COLCHICINE CONCURRENTLY WITH AN ANTIPLATELET AGENT
Methods of treating and/or preventing a cardiovascular event in a patient, the method comprising orally administering a colchicine to a patient who is...
2017/0326082 PROPHYLAXIS AND TREATMENT OF PRETERM BIRTH ASSOCIATED DEVELOPMENTAL DISORDERS
A composition for the prophylaxis and/or treatment of a developmental disorder which is associated with preterm birth, and a method for the diagnosis and/or...
2017/0326081 GENOTYPE- OR PHENOTYPE-BASED DRUG FORMULATION
The invention relates to a combination of two or more pharmaceutically active substances, of which at least one is a metabolic product ("metabolite") of the...
2017/0326080 Genotype- or Phenotype-Based Drug Formulations
The invention relates to a combination of two or more pharmaceutically active substances, of which at least one is a metabolic product ("metabolite") of the...
2017/0326079 Use of 1-phenyl-3-dimethylaminopropane Compounds for Treating Rheumatoid Pain
The use of 1-phenyl-3-dimethylaminopropane compounds for the treatment of rheumatoid pain, especially rheumatoid arthritic pain, very especially preferably...
2017/0326078 FLUORINATED CBD COMPOUNDS, COMPOSITIONS AND USES THEREOF
The present invention relates to fluorine substituted CBD compounds, compositions thereof and uses thereof for the preparation of medicaments.
2017/0326077 HOMOGENOUS COMPOSITION AND METHODS OF MAKING THE SAME
A hydrated lecithin carrier vesicle composition includes a lecithin-derived membrane-forming lipid vesicle in conditioned water for incorporation of an active...
2017/0326076 PANICEIN COMPOUNDS, COMPOSITIONS AND USES THEREOF
The present invention relates to the fields of medicine and cancer treatment. The invention more specifically relates to the use of a panicein or a derivative...
2017/0326075 THYMOL AND CARVACOL FOR USE IN MEDICINE
The invention provides therapeutic methods comprising the administration of thymol or carvacrol, or a pharmaceutically acceptable salt or prodrug thereof. The...
2017/0326074 NANOPARTICLES FOR ENCAPSULATING COMPOUNDS, THE PREPARATION AND USES THEREOF
The present invention relates to nanoparticles for encapsulating biologically active compounds, comprising a matrix of new polymer conjugates. The invention...
2017/0326073 JANUS NANOPARTICLE AND METHOD FOR PRODUCING THE SAME
It is an object of the present invention to provide a Janus nanoparticle, into which a drug can be encapsulated by a simple method, and a method for producing...
2017/0326071 YEAST CELL WALL PARTICLES FOR RECEPTOR-TARGETED NANOPARTICLE DELIVERY
The present invention generally relates to yeast cell wall microparticles loaded with nanoparticles for receptor-targeted nanoparticle delivery. In particular,...
2017/0326070 ANTHOSTEMA SENEGALENSE-BASED COMPOSITION FOR USE AS AN ANTI-AIDS DRUG
A pharmaceutical composition based on Anthostema senegalense is used as a drug in the treatment of HIV infection, AIDS and accompanying clinical ...
2017/0326069 Pharmaceutical Composition Comprising a GLP-1-Agonist and Methionine
A liquid composition comprising a GLP-1 agonist and/or a pharocoligically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable...
2017/0326068 JELLY FOR ASSISTING IN TAKING DRUG
Provided is a jelly for assisting in taking a drug that reduces a possibility of aspiration and makes it possible to deliver a drug efficiently to the...
2017/0326067 PHARMACEUTICAL COMPOSITION CONTAINING BUDESONIDE AND FORMOTEROL
The present invention relates to inhalation formulations of drugs in the form of dry powder for inhalation administration, suitable for the treatment of...
2017/0326066 METHOD OF TREATING HYPERTENSION
The present invention relates to methods and composition for treatment of hypertension. Particularly the present invention provides a method of treating...
2017/0326065 METHODS AND COMPOSITION FOR TREATMENT OF CARDIOVASCULAR CONDITIONS
The present invention relates to methods for treatment of cardiovascular conditions selected from high blood pressure, heart failure, or heart attack. The...
2017/0326064 Ocular Delivery of Drugs
The present invention relates to an aqueous composition comprising a macrolide immunosuppressant drug at a concentration of less than 2% w/v and an amphiphilic...
2017/0326063 TOPICAL SYSTEMS AND METHODS FOR TREATING SEXUAL DYSFUNCTION
The present invention generally relates to compositions and methods for topical or transdermal delivery, and treatment of sexual dysfunction. The compositions...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.